Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.75%1.8T | 24.69%1.74T | -2.93%5.88T | 16.58%1.55T | -3.35%1.45T | -0.18%1.48T | -19.79%1.4T | 28.79%6.06T | 3.26%1.33T | 34.90%1.5T |
Net interest income | 6.20%685.42B | 40.91%823.11B | -16.02%2.46T | 10.76%657.82B | -13.49%570.24B | -6.00%645.38B | -40.79%584.13B | 43.20%2.93T | 7.54%593.9B | 32.14%659.2B |
-Net interest income | 7.69%2T | 40.81%2.35T | 40.95%7.47T | 39.64%2.12T | 28.14%1.81T | 60.70%1.86T | 38.64%1.67T | 104.79%5.3T | 117.30%1.52T | 125.56%1.41T |
-Including:Interest income from loans and lease | -2.59%972.17B | 31.53%1.19T | 41.43%4T | 30.84%1.13T | 19.81%968.03B | 50.67%998.02B | 83.11%901.94B | 70.50%2.83T | 91.95%866.3B | 99.88%807.99B |
-Including:Interest income from deposits | ---- | ---- | 94.67%709.39B | ---- | ---- | ---- | ---- | 516.88%364.41B | ---- | ---- |
-Including:Interest income from securities | 1.02%374.35B | 41.61%444.66B | -5.53%1.37T | 31.16%393.75B | 5.62%293.74B | 32.17%370.59B | -47.12%314.01B | 165.55%1.45T | 100.74%300.21B | 120.39%278.1B |
-Including:Other interest income | 33.53%657.9B | 58.65%722.04B | 68.66%838.86B | -299.73%-658.85B | 67.79%549.87B | 128.65%492.71B | 282.43%455.13B | 66.60%497.37B | -1,081.62%-164.82B | 240.07%327.71B |
-Total interest expense | 8.48%1.32T | 40.75%1.53T | 111.20%5.01T | 58.12%1.47T | 64.51%1.24T | 157.80%1.22T | 396.71%1.09T | 336.20%2.37T | 526.94%927.64B | 489.84%754.6B |
-Including:Interest expense for deposit | 1.56%490.03B | 43.94%601.43B | 122.98%2.61T | 94.73%1.25T | 75.78%465.66B | 164.57%482.48B | 395.63%417.83B | 466.12%1.17T | 797.80%639.49B | 545.95%264.91B |
-Including:Interest expense for short termdebt | ---- | ---- | 104.54%166.39B | ---- | ---- | ---- | ---- | 1,932.20%81.35B | ---- | ---- |
-Including:Interest expense for long term debt and capital securities | ---- | ---- | 40.33%584.72B | ---- | ---- | ---- | ---- | 51.94%416.68B | ---- | ---- |
-Including:Other interest expense | 13.02%828.97B | 38.76%928.46B | 126.82%560.8B | -142.77%-1.62T | 58.41%775.74B | 153.53%733.45B | 397.40%669.11B | 660.73%247.25B | -192.41%-666.27B | 463.36%489.7B |
Non interest income | 33.77%1.12T | 13.05%919.56B | 9.30%3.42T | 21.29%891.42B | 4.58%882.71B | 4.84%834.62B | 7.62%813.45B | 17.71%3.13T | 0.04%734.96B | 37.14%844.09B |
-Fees and commissions | 10.80%495.64B | 20.36%483.13B | 7.39%1.82T | 19.70%535.56B | -8.28%436.36B | 10.98%447.32B | 8.74%401.42B | 7.66%1.7T | 0.73%447.43B | 23.31%475.77B |
-Other non interest income | 61.81%501.9B | 8.39%328.33B | 16.11%1.23T | 0.71%308.82B | 393.38%311.45B | -7.20%310.19B | -15.45%302.92B | 24.60%1.06T | 32.22%306.63B | -63.62%63.13B |
-Gain loss on sale of assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Trading gain /loss | 54.27%118.97B | -0.92%108.1B | -1.39%368.17B | 346.36%47.05B | -55.80%134.9B | 31.13%77.12B | 283.56%109.1B | 60.60%373.35B | -132.59%-19.1B | 443.76%305.19B |
Credit losses provision | 86.38%-19.01B | -300.46%-166.76B | 26.22%-497.91B | -23.10%-234.29B | 65.77%-82.39B | 17.82%-139.58B | 43.71%-41.64B | -103.61%-674.84B | 37.42%-190.33B | -432.46%-240.68B |
Non interest expense | -2.04%873.5B | 18.71%985.85B | -20.92%3.79T | 11.96%1.16T | -19.40%905.33B | -19.01%891.66B | -45.67%830.45B | 46.15%4.79T | 8.27%1.03T | 46.31%1.12T |
Selling and administrative expenses | 1.63%731.7B | 19.83%844.87B | -1.63%2.92T | 4.48%797.3B | -10.07%698.54B | -1.28%719.99B | 0.71%705.05B | 8.10%2.97T | 3.08%763.13B | 15.43%776.79B |
-General and administrative expense | 1.63%731.7B | 19.83%844.87B | -1.63%2.92T | 4.48%797.3B | -10.07%698.54B | -1.28%719.99B | 0.71%705.05B | 8.10%2.97T | 3.08%763.13B | 15.43%776.79B |
Other non-interest expense | -17.41%141.79B | 12.42%140.97B | -52.41%865.23B | 32.97%361.36B | -40.30%206.8B | -53.80%171.68B | -84.86%125.4B | 243.69%1.82T | 26.09%271.76B | 265.67%346.4B |
Income from associates and other participating interests | 8.22%114.05B | -28.43%143.09B | 24.89%531.8B | 149.30%169.91B | -52.22%56.59B | -9.31%105.38B | 62.49%199.92B | -3.57%425.83B | -41.79%68.16B | 11.59%118.43B |
Special income (charges) | 11.99%-17.7B | 113.01%2.91B | -114.10%-77.45B | -106.00%-36.8B | 124.98%1.8B | 43.27%-20.11B | -2.07%-22.35B | 1,249.46%549.2B | 656.05%613.76B | 1.58%-7.22B |
Less:Impairment of capital assets | -29.43%14.24B | -26.97%2.63B | 71.23%31.11B | -21.48%5.07B | -53.62%2.26B | 230.53%20.18B | 391.26%3.6B | -89.57%18.17B | -95.30%6.46B | -68.11%4.87B |
Less:Other special charges | 674.67%431M | -129.51%-5.53B | -54.98%46.25B | -60.10%31.64B | -272.82%-4.06B | -22.95%-75M | -11.39%18.75B | 265.38%102.74B | 2,524.03%79.29B | 423.83%2.35B |
Gain on sale of business | ---- | ---- | -100.01%-93M | -100.01%-93M | --0 | ---- | ---- | 943.31%670.11B | 2,848.03%699.51B | --0 |
Other non-operating income (expenses) | ||||||||||
Income before tax | 88.34%1.01T | 4.69%736.06B | 30.59%2.05T | -63.16%289.39B | 108.93%523.62B | 82.45%534.03B | 191.67%703.06B | 5.37%1.57T | 2,234.50%785.56B | -37.39%250.62B |
Income tax | 86.83%275.42B | 20.62%153.79B | 29.42%478.34B | 696.95%71.13B | 9.59%132.29B | -4.08%147.42B | 19.03%127.5B | 30.41%369.61B | 72.24%-11.92B | 20.01%120.71B |
Earnings from equity interest net of tax | ||||||||||
Net income | 88.91%730.36B | 1.17%582.28B | 30.95%1.57T | -72.63%218.26B | 201.24%391.33B | 178.12%386.61B | 329.77%575.56B | -0.51%1.2T | 941.53%797.48B | -56.65%129.91B |
Net Income continuous operations | 88.91%730.36B | 1.17%582.28B | 30.95%1.57T | -72.63%218.26B | 201.24%391.33B | 178.12%386.61B | 329.77%575.56B | -0.51%1.2T | 941.53%797.48B | -56.65%129.91B |
Noncontrolling interests | 58.39%28.06B | 53.64%26.38B | -3.39%80.98B | 5.13%25.39B | 16.13%20.7B | -17.99%17.72B | -15.15%17.17B | 10.86%83.82B | 49.80%24.16B | 66.26%17.82B |
Net income attributable to the company | 90.38%702.3B | -0.45%555.89B | 33.52%1.49T | -75.06%192.87B | 230.68%370.64B | 214.20%368.89B | 391.17%558.39B | -1.27%1.12T | 1,179.44%773.32B | -61.21%112.08B |
Net income attributable to common stockholders | 90.38%702.3B | -0.45%555.89B | 33.52%1.49T | -75.06%192.87B | 230.68%370.64B | 214.20%368.89B | 391.17%558.39B | -1.27%1.12T | 1,179.44%773.32B | -61.21%112.08B |
Diluted earnings per share | 96.25%60.19 | 2.28%47.5 | 37.39%124.64 | -73.66%16.6 | 236.56%30.93 | 223.86%30.67 | 414.29%46.44 | 2.58%90.72 | 1,160.60%63.03 | -59.28%9.19 |
Basic earnings per share | 96.63%60.17 | 2.40%47.4 | 37.51%124.32 | -73.74%16.54 | 239.82%30.89 | 225.88%30.6 | 417.79%46.29 | 2.68%90.41 | 1,188.14%62.99 | -59.55%9.09 |
Dividend per share | 21.95%25 | --0 | 28.13%41 | 28.13%20.5 | --0 | 28.13%20.5 | --0 | 14.29%32 | 10.34%16 | --0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |